Publications:3
- Home
- Profiles
Mount Sinai DoctorsScott Hammerman, MD
Dermatology, Internal Medicine
No Patient Experience Ratings
- About Me
- Education & Certifications
- Insurance
- Publications
- Industry Relationships
About Me
Language
Position
Hospital Affiliations
- The Mount Sinai Hospital
About Me
Language
Position
Hospital Affiliations
- The Mount Sinai Hospital
Education
MD, Chicago Medical School at Rosalind Franklin University
Residency, Dermatology
Lutheran General Hospital
Residency, Dermatology
Roger Williams Medical Center
Certifications
American Board of Dermatology
Insurance Information
Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).
Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.
Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.
Publications
Selected Publications
- Low-grade elastic compression regimen for venous leg ulcers - an effective compromise for patients requiring daily dressing changes. Ganary Dabiri, Scott Hammerman, Polly Carson, Vincent Falanga. International Wound Journal
- Wound edge biopsy sites in chronic wounds heal rapidly and do not result in delayed overall healing of the wounds. Jaymie Panuncialman, Scott Hammerman, Polly Carson, Vincent Falanga. Wound Repair and Regeneration
- Completeness in the reporting of dermatologic adverse drug reactions associated with monoclonal antibody epidermal growth factor receptor inhibitors in phase II and III colorectal cancer clinical trials. Kimberly A. Bauer, Scott Hammerman, Bernardo Rapoport, Mario E. Lacouture. Clinical Colorectal Cancer
Industry Relationships
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.
Dr. Hammerman has not yet completed reporting of Industry relationships.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.